Edwards Lifesciences said yesterday that it won CE Mark approval in the European Union for its HemoSphere blood flow monitor.
Hemodynamic monitoring, the measurement of a patient’s blood circulation and cardiac function, enables clinicians to evaluate whether a patient is receiving enough oxygen to their organs and tissues.
The device includes visual clinical support screens and is compatible with the Edwards Swan-Ganz pulmonary artery catheter and Oximetry catheters.
